2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-105515
    TJN 220
    TJN 220 is a synthetic derivative of orally active tetrandrine (HY-13764). TJN 220 has a long-lasting and stable antihypertensive effect in various hypertension models. TJN 220 is suitable for controlling nighttime hypertension and does not cause reflex tachycardia. TJN 220 can be used for research on hypertension.
    TJN 220
  • HY-147539
    Antitumor agent-65
    Antitumor agent-65 (Compound 5) is an analogue/derivative of (-)-cleistenolide. Antitumor agent-65 has the potential for the research of cancer diseases.
    Antitumor agent-65
  • HY-100072
    (2E,4E,6Z)-Methyl deca-2,4,6-trienoate
    (2E,4E,6Z)-Methyl deca-2,4,6-trienoate (Methyl (2E,4E,6Z)-decatrienoate) is the aggregation pheromone of the brown-winged green bug, Plautia stali. (2E,4E,6Z)-Methyl deca-2,4,6-trienoate exposed to daylight in solutions and/or on dispensers used for field trapping can readily isomerize to form complex mixtures of isomers, thus causing a concern about lure stability and longevity.
    (2E,4E,6Z)-Methyl deca-2,4,6-trienoate
  • HY-165497
    Felbinac tris
    Felbinac tris (4-Biphenylacetic acid tris) is a potent analgesic agent. Felbinac tris metabolized into 4'-hydroxyfelbinac and is excreted via urine and feces. Felbinac tris has the potential for the research of post-operative pain.
    Felbinac tris
  • HY-176896
    NHS-C2-(C-acid)-N-bis(C-Py-m-acid)
    NHS-C2-(C-acid)-N-bis(C-Py-m-acid) (Compound 8) is a key intermediate for the synthesis of porphyrin-chelate conjugate.
    NHS-C2-(C-acid)-N-bis(C-Py-m-acid)
  • HY-P11049
    Stroke-homing peptide
    Stroke-homing peptide is a homing peptide. Stroke-homing peptide can home to ischemic stroke brain tissue and detect the apoptotic neuronal cells. Stroke-homing peptide can be used for the research of molecular imaging and selective drug delivery to stroke tissue.
    Stroke-homing peptide
  • HY-164105
    S-Lactylglutathione
    S-Lactylglutathione is a substrate of lactoylglutathione lyase [EC 4.4. 1.5] in pyruvate metabolism.
    S-Lactylglutathione
  • HY-176780
    Gαi2-IN-1
    Gαi2-IN-1 (Compound 14) is a Gαi2 inhibitor. Gαi2-IN-1 significantly inhibits cancer cells migration induced by the chemotherapeutic drug, such as Vorinostat (HY-10221) and Docetaxel (HY-B0011). Gαi2-IN-1 can be used for cancers like prostate, breast and ovarian cancer research.
    Gαi2-IN-1
  • HY-P10621
    SHLP-1
    SHLP-1 is a mitochondrial-derived peptide, a biologically active microprotein encoded by the 16S ribosomal RNA (MT-RNR2) gene. SHLP-1 can be used in the research of diabetes, Alzheimer's disease, cardiovascular disease and prostate cancer.
    SHLP-1
  • HY-106530
    Gitoformate
    Gitoformate (AC 2770) is a semisynthetic cardiac glycoside. Gitoformate can be used for renal function research.
    Gitoformate
  • HY-162847
    S24–14
    S24–14 is a potent antiosteoporosis agent. S24–14 inhibits osteoclastogenesis with an IC50 value of 0.40 µM. S24–14 induces osteoblast differentiation. S24–14 suppresses bone loss.
    S24–14
  • HY-N16393
    (-)-Mitorubrinol
    (-)-Mitorubrinol is found in the marine-derived Penicillium purpurogenum G59 strain induced by diethyl sulfate (DES). (-)-Mitorubrinol exhibits inhibitory effects on K562, HL-60, HeLa, and BGC-823 cancer cell lines.
    (-)-Mitorubrinol
  • HY-P11103
    WSHPQFEK
    WSHPQFEK has a high affinity for Streptavidin and can be used as a tag peptide for recombinant protein separation, purification, and detection.
    WSHPQFEK
  • HY-120695
    Nafiverine
    Nafiverine is an antispasmodic agent. Nafiverine shows a high myolytic activity on the smooth muscles of the ileum, uterus, and coronary vessels.
    Nafiverine
  • HY-178683
    ALV-05-077-01
    ALV-05-077-01 is a BLC6/BLC6B degrader. ALV-05-077-01 depletes endogenous BCL6 levels in SuDHL4 cells (high BCL6 expression) and BCL6B levels in KYO1 cells (high BCL6B expression). ALV-05-077-01 can be used for the study of hematological malignancies.
    ALV-05-077-01
  • HY-W107722
    IN04
    IN04 is a inhibitor of leucine-rich repeat kinase 1 (LRRK1). IN04 can completely block the binding of ATP to the human LRRK1 kinase domain, thereby inhibiting the kinase activity of LRRK1. IN04 can significantly impair the bone resorption ability of osteoclasts, with an IC50 value of 5.72 μM. IN04 can be used for the study of osteoporosis.
    IN04
  • HY-N1014
    11α,12β-Di-O-acetyltenacigenin B
    11α,12β-Di-O-acetyltenacigenin B is a polyoxypregnane compound isolated from the CHCl(3)-soluble fraction of the ethanolic extract of the stem of Marsdenia tenacissima.
    11α,12β-Di-O-acetyltenacigenin B
  • HY-163025
    Cyanazine-3-mercaptopropanoic acid
    Cyanazine-3-mercaptopropanoic acid (compound 6), a coating hapten, is a stable carrier-hapten complex. Polyclonal antibody obtained were with a high titer, with the IC50 of 10.2 ng/mL for Cyanazine-3-mercaptopropanoic acid.
    Cyanazine-3-mercaptopropanoic acid
  • HY-W727466
    4,6-Dimethyldodecane
    4,6-Dimethyldodecane is an alkane. 4,6-Dimethyldodecane can be derived from the oil of T. decandra. 4,6-Dimethyldodecane can be used in bacterial infection research.
    4,6-Dimethyldodecane
  • HY-154978
    Cisplatin-resistant cells-IN-1
    Cisplatin-resistant cells-IN-1 (Compound 8) has high cytotoxicity against Cisplatin (HY-17394)-resistant cells. Cisplatin-resistant cells-IN-1 reduces the metabolic activity effectively in the low nanomolar range (IC50: 0.14–1.79 μM in A549/A549-R, K562/K562-R, and MCF-7/MCF-7TamR cells).
    Cisplatin-resistant cells-IN-1
Cat. No. Product Name / Synonyms Application Reactivity